INTEGRA LIFESCIENCES HOLDINGS CORP Increase (Decrease) in Accounts Payable and Accrued Liabilities
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$34.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-07-29
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$15.20M, a 195.45% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$19.19M.
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $23.02M.
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $5.78M, a 15.29% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $26.72M.
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was -$2.67M.
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was -$20.23M, a 216.64% decline from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $17.34M, a 47.24% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$15.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$34.38M 10-Q · filed 2026-07-29 | -$11.36M derived: sum of 3 quarters · filed 2026-07-29 | -$5.58M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | -$19.19M 10-Q · filed 2026-05-05 | $3.83M derived: sum of 2 quarters · filed 2026-05-05 | $9.62M derived: sum of 3 quarters · filed 2026-05-05 | $25.54M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | $23.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $28.80M derived: sum of 2 quarters · filed 2026-02-26 | $44.72M derived: sum of 3 quarters · filed 2026-07-29 | $26.72M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $5.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $21.70M derived: sum of 2 quarters · filed 2026-07-29 | $3.70M 10-Q · filed 2025-10-30 | -$1.66M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | $15.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$2.08M 10-Q · filed 2026-07-29 | -$7.44M derived: sum of 3 quarters · filed 2026-07-29 | -$612.00K derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | -$18.00M 10-Q · filed 2026-05-05 | -$23.36M derived: sum of 2 quarters · filed 2026-05-05 | -$16.53M derived: sum of 3 quarters · filed 2026-05-05 | -$1.46M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | -$5.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.47M derived: sum of 2 quarters · filed 2026-02-26 | $16.54M derived: sum of 3 quarters · filed 2026-02-26 | -$2.67M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $6.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $21.90M derived: sum of 2 quarters · filed 2025-10-30 | $2.69M 10-Q · filed 2025-10-30 | $4.60M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $15.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$4.14M 10-Q · filed 2025-07-31 | -$2.23M derived: sum of 3 quarters · filed 2026-02-26 | -$8.47M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | -$19.21M 10-Q · filed 2025-05-05 | -$17.30M derived: sum of 2 quarters · filed 2026-02-26 | -$23.54M derived: sum of 3 quarters · filed 2026-02-26 | -$34.45M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$4.33M derived: sum of 2 quarters · filed 2026-02-26 | -$15.24M derived: sum of 3 quarters · filed 2026-02-26 | -$20.23M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | -$6.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | -$17.16M derived: sum of 2 quarters · filed 2024-11-04 | -$22.14M 10-Q · filed 2024-11-04 | -$4.00M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | -$10.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-29 | -$15.90M 10-Q · filed 2024-07-29 | $2.25M derived: sum of 3 quarters · filed 2025-02-25 | $16.00M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | -$4.98M 10-Q · filed 2024-05-06 | $13.16M derived: sum of 2 quarters · filed 2025-02-25 | $26.91M derived: sum of 3 quarters · filed 2025-02-25 | $22.11M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | $18.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $31.90M derived: sum of 2 quarters · filed 2025-02-25 | $27.10M derived: sum of 3 quarters · filed 2025-02-25 | $17.34M 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | $13.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | $8.95M derived: sum of 2 quarters · filed 2023-10-25 | -$803.00K 10-Q · filed 2023-10-25 | -$1.79M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | -$4.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | -$14.56M 10-Q · filed 2023-07-27 | -$15.54M derived: sum of 3 quarters · filed 2024-02-28 | -$8.96M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | -$9.75M 10-Q · filed 2023-04-26 | -$10.74M derived: sum of 2 quarters · filed 2024-02-28 | -$4.16M derived: sum of 3 quarters · filed 2024-02-28 | $8.67M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | -$984.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $5.60M derived: sum of 2 quarters · filed 2024-02-28 | $18.43M derived: sum of 3 quarters · filed 2024-02-28 | $32.87M 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | $6.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26 | $19.41M derived: sum of 2 quarters · filed 2022-10-26 | $33.86M 10-Q · filed 2022-10-26 | $43.52M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $12.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $27.28M 10-Q · filed 2022-07-27 | $36.94M derived: sum of 3 quarters · filed 2023-02-22 | $58.44M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $14.45M 10-Q · filed 2022-04-27 | $24.11M derived: sum of 2 quarters · filed 2023-02-22 | $45.61M derived: sum of 3 quarters · filed 2023-02-22 | -$2.65M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $9.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $31.16M derived: sum of 2 quarters · filed 2023-02-22 | -$17.10M derived: sum of 3 quarters · filed 2023-02-22 | -$57.51M 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $21.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$26.77M derived: sum of 2 quarters · filed 2021-11-02 | -$67.18M 10-Q · filed 2021-11-02 | -$52.88M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | -$48.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$88.67M 10-Q · filed 2021-07-29 | -$74.37M derived: sum of 3 quarters · filed 2022-02-24 | -$90.42M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | -$40.41M 10-Q · filed 2021-04-29 | -$40.23M 10-Q · filed 2020-05-07 | -$26.11M derived: sum of 2 quarters · filed 2022-02-24 | -$42.16M derived: sum of 3 quarters · filed 2022-02-24 | -$31.13M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | $14.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$1.74M derived: sum of 2 quarters · filed 2022-02-24 | $9.28M derived: sum of 3 quarters · filed 2022-02-24 | $14.67M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | -$16.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$5.02M derived: sum of 2 quarters · filed 2020-10-29 | $366.00K 10-Q · filed 2020-10-29 | -$5.46M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-06-30 | $11.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $16.41M 10-Q · filed 2020-08-10 | $10.58M derived: sum of 3 quarters · filed 2021-02-23 | $23.40M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-03-31 | $5.39M 10-Q · filed 2020-05-07 | -$443.00K derived: sum of 2 quarters · filed 2021-02-23 | $12.38M derived: sum of 3 quarters · filed 2021-02-23 | $6.00M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2018-12-31 | -$5.83M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $6.99M derived: sum of 2 quarters · filed 2021-02-23 | $614.00K derived: sum of 3 quarters · filed 2021-02-23 | $3.59M 10-K · filed 2021-02-23 | ||||
| 2018-09-30 | $12.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $6.44M derived: sum of 2 quarters · filed 2019-10-25 | $9.42M 10-Q · filed 2019-10-25 | $80.72M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-06-30 | -$6.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | -$3.40M 10-Q · filed 2019-07-25 | $67.89M derived: sum of 3 quarters · filed 2020-02-21 | $71.63M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-03-31 | $2.97M 10-Q · filed 2019-04-29 | $74.27M derived: sum of 2 quarters · filed 2020-02-21 | $78.01M derived: sum of 3 quarters · filed 2020-02-21 | $88.11M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2017-12-31 | $71.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $75.03M derived: sum of 2 quarters · filed 2020-02-21 | $85.13M derived: sum of 3 quarters · filed 2020-02-21 | $95.32M 10-K · filed 2020-02-21 | ||||
| 2017-09-30 | $3.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $13.83M derived: sum of 2 quarters · filed 2018-11-01 | $24.02M 10-Q · filed 2018-11-01 | $17.78M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $10.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $20.29M 10-Q · filed 2018-07-26 | $14.04M derived: sum of 3 quarters · filed 2019-02-26 | $17.64M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | $10.19M 10-Q · filed 2018-04-26 | $8.94M 10-Q · filed 2017-04-26 | $3.94M derived: sum of 2 quarters · filed 2019-02-26 | $7.54M derived: sum of 3 quarters · filed 2019-02-26 | -$2.28M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | -$6.25M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$2.65M derived: sum of 2 quarters · filed 2019-02-26 | -$12.47M derived: sum of 3 quarters · filed 2019-02-26 | -$414.00K 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | $3.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | -$6.23M derived: sum of 2 quarters · filed 2017-10-26 | $5.83M 10-Q · filed 2017-10-26 | -$1.75M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | -$9.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $2.24M 10-Q · filed 2017-07-26 | -$5.35M derived: sum of 3 quarters · filed 2018-03-01 | -$13.51M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $12.06M 10-Q · filed 2017-04-26 | $8.01M 10-Q · filed 2016-04-27 | $4.47M derived: sum of 2 quarters · filed 2018-03-01 | -$3.69M derived: sum of 3 quarters · filed 2018-03-01 | $24.61M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | -$7.58M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$15.74M derived: sum of 2 quarters · filed 2018-03-01 | $12.55M derived: sum of 3 quarters · filed 2018-03-01 | $8.21M 10-K · filed 2018-03-01 | $1.63M 10-K · filed 2016-02-26 | |||
| 2015-09-30 | -$8.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $20.14M derived: sum of 2 quarters · filed 2016-10-28 | $15.79M 10-Q · filed 2016-10-28 | $9.35M 10-Q · filed 2015-11-04 | $12.08M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2015-06-30 | $28.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $23.95M 10-Q · filed 2016-07-28 | $19.61M 10-Q · filed 2015-07-31 | $20.23M derived: sum of 3 quarters · filed 2017-02-23 | $19.91M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2015-03-31 | -$4.35M 10-Q · filed 2016-04-27 | -$1.89M 10-Q · filed 2015-05-01 | -$8.06M derived: sum of 2 quarters · filed 2017-02-23 | -$8.38M derived: sum of 3 quarters · filed 2017-02-23 | $902.00K derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2014-12-31 | -$3.72M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$4.04M derived: sum of 2 quarters · filed 2017-02-23 | $5.25M derived: sum of 3 quarters · filed 2017-02-23 | $811.00K 10-K · filed 2017-02-23 | $2.43M 10-K · filed 2015-02-27 | |||
| 2014-09-30 | -$320.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $8.97M derived: sum of 2 quarters · filed 2015-11-04 | $4.53M 10-Q · filed 2015-11-04 | $8.79M 10-Q · filed 2014-11-07 | -$8.32M derived: sum of 4 quarters · filed 2016-02-26 | |||
| 2014-06-30 | $9.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $4.85M 10-Q · filed 2015-07-31 | -$8.00M derived: sum of 3 quarters · filed 2016-02-26 | $3.29M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | -$4.44M 10-Q · filed 2015-05-01 | -$17.29M derived: sum of 2 quarters · filed 2016-02-26 | -$6.00M derived: sum of 3 quarters · filed 2016-02-26 | -$2.59M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | -$12.85M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$1.56M derived: sum of 2 quarters · filed 2016-02-26 | $1.85M derived: sum of 3 quarters · filed 2016-02-26 | $1.33M 10-K · filed 2016-02-26 | $9.95M 10-K · filed 2014-02-27 | |||
| 2013-09-30 | $11.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $14.70M derived: sum of 2 quarters · filed 2014-11-07 | $14.19M 10-Q · filed 2014-11-07 | -$13.41M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $3.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $2.89M 10-Q · filed 2014-08-05 | -$24.71M derived: sum of 3 quarters · filed 2015-02-27 | -$25.56M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | -$515.00K 10-Q · filed 2014-05-01 | -$28.11M derived: sum of 2 quarters · filed 2015-02-27 | -$28.96M derived: sum of 3 quarters · filed 2015-02-27 | -$23.71M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | -$27.60M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$28.45M derived: sum of 2 quarters · filed 2015-02-27 | -$23.19M derived: sum of 3 quarters · filed 2015-02-27 | -$21.07M 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | -$850.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-10-30 | $4.41M derived: sum of 2 quarters · filed 2013-10-30 | $6.53M 10-Q · filed 2013-10-30 | -$1.13M derived: sum of 4 quarters · filed 2014-06-20 | ||||
| 2012-06-30 | $5.26M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2013-08-02 | $7.38M 10-Q/A · filed 2013-08-02 | -$279.00K derived: sum of 3 quarters · filed 2014-06-20 | -$8.89M derived: sum of 4 quarters · filed 2014-06-20 | ||||
| 2012-03-31 | $2.12M 10-Q · filed 2013-05-02 | -$5.54M derived: sum of 2 quarters · filed 2014-06-20 | -$14.14M derived: sum of 3 quarters · filed 2014-06-20 | -$6.92M derived: sum of 4 quarters · filed 2014-06-20 | ||||
| 2011-12-31 | -$7.66M derived: 8-K 12 month − 10-Q 9 month · filed 2014-06-20 | -$16.27M derived: sum of 2 quarters · filed 2014-06-20 | -$9.04M derived: sum of 3 quarters · filed 2014-06-20 | -$11.84M 8-K · filed 2014-06-20 | ||||
| 2011-09-30 | -$8.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | -$1.39M derived: sum of 2 quarters · filed 2012-10-24 | -$4.18M 10-Q · filed 2012-10-24 | -$9.80M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $7.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-31 | $4.42M 10-Q · filed 2012-07-31 | -$1.19M derived: sum of 3 quarters · filed 2013-02-26 | $5.12M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | -$2.80M 10-Q · filed 2012-04-26 | -$8.41M derived: sum of 2 quarters · filed 2013-02-26 | -$2.10M derived: sum of 3 quarters · filed 2013-02-26 | $743.00K derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2010-12-31 | -$5.61M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $695.00K derived: sum of 2 quarters · filed 2013-02-26 | $3.54M derived: sum of 3 quarters · filed 2013-02-26 | $6.74M 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | $6.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $9.15M derived: sum of 2 quarters · filed 2011-10-31 | $12.35M 10-Q · filed 2011-10-31 | $22.07M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-06-30 | $2.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $6.04M 10-Q · filed 2011-08-01 | $15.76M derived: sum of 3 quarters · filed 2012-02-27 | $19.52M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-03-31 | $3.20M 10-Q · filed 2011-04-28 | $12.91M derived: sum of 2 quarters · filed 2012-02-27 | $16.68M derived: sum of 3 quarters · filed 2012-02-27 | |||||
| 2009-12-31 | $9.72M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $13.48M derived: sum of 2 quarters · filed 2012-02-27 | $4.55M 10-K · filed 2012-02-27 | |||||
| 2009-09-30 | $3.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | -$5.17M 10-Q · filed 2010-10-28 | ||||||
| 2009-06-30 | -$8.93M 10-Q · filed 2010-07-29 | |||||||
| 2008-12-31 | -$17.26M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |